Oracle Partners Lp - Net Worth and Insider Trading
Oracle Partners Lp Net Worth
The estimated net worth of Oracle Partners Lp is at least $0 dollars as of 2024-12-27. Oracle Partners Lp is the 10% Owner of Accelerated Pharma Inc and owns about 247,651 shares of Accelerated Pharma Inc (ACCP) stock worth over $0. Details can be seen in Oracle Partners Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Oracle Partners Lp has not made any transactions after 2007-11-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Oracle Partners Lp
Oracle Partners Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Oracle Partners Lp owns 6 companies in total, including Soleno Therapeutics Inc (SLNO) , Aspira Womens Health Inc (AWH) , and Biolase Inc (BIOLQ) among others .
Click here to see the complete history of Oracle Partners Lp’s form 4 insider trades.
Insider Ownership Summary of Oracle Partners Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SLNO | Soleno Therapeutics Inc | 2020-06-05 | 10 percent owner |
| AWH | Aspira Womens Health Inc | 2020-06-08 | 10 percent owner |
| BIOLQ | Biolase Inc | 2019-10-29 | 10 percent owner |
 | | 2021-01-26 | other: * See Remarks |
| | 2016-07-27 | 10 percent owner |
| | 2005-02-01 | 10 percent owner |
Oracle Partners Lp Latest Holdings Summary
Oracle Partners Lp currently owns a total of 1 stock. Oracle Partners Lp owns 247,651 shares of Accelerated Pharma Inc (ACCP) as of November 9, 2007, with a value of $0.
Latest Holdings of Oracle Partners Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACCP | Accelerated Pharma Inc | 2007-11-09 | 247,651 | 0.00 | 0 |
Holding Weightings of Oracle Partners Lp
Oracle Partners Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Oracle Partners Lp has made a total of 0 transactions in Accelerated Pharma Inc (ACCP) over the past 5 years. The most-recent trade in Accelerated Pharma Inc is the sale of 0 shares on November 9, 2007, which brought Oracle Partners Lp around $0.
Insider Trading History of Oracle Partners Lp
- 1
Oracle Partners Lp Trading Performance
Oracle Partners Lp Ownership Network
Oracle Partners Lp Owned Company Details
What does Soleno Therapeutics Inc do?
Who are the key executives at Soleno Therapeutics Inc?
Oracle Partners Lp is the 10 percent owner of Soleno Therapeutics Inc. Other key executives at Soleno Therapeutics Inc include Chief Financial Officer James H Mackaness , See Remarks Patricia C Hirano , and See Remarks Kristen Yen .
Soleno Therapeutics Inc (SLNO) Insider Trades Summary
Over the past 18 months, Oracle Partners Lp made no insider transaction in Soleno Therapeutics Inc (SLNO). Other recent insider transactions involving Soleno Therapeutics Inc (SLNO) include a net sale of 479,373 shares made by Bhatnagar Anish , a net sale of 79,014 shares made by Kristen Yen , and a net sale of 47,490 shares made by Patricia C Hirano .
In summary, during the past 3 months, insiders sold 35,926 shares of Soleno Therapeutics Inc (SLNO) in total and bought 0 shares, with a net sale of 35,926 shares. During the past 18 months, 2,825,824 shares of Soleno Therapeutics Inc (SLNO) were sold and 866,789 shares were bought by its insiders, resulting in a net sale of 1,959,035 shares.
Soleno Therapeutics Inc (SLNO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Soleno Therapeutics Inc Insider Transactions
Oracle Partners Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Oracle Partners Lp. You might contact Oracle Partners Lp via mailing address: 200 Greenwich Ave, 3rd Fl, Greenwich Ct 06830.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
